← All stocks

BIOMARIN PHARMACEUTICAL INC

BMRN Net selling

CIK 0001048477 #822 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$1.16M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$1.16M

1 of 1 sales

Net

−$1.16M

−$1.16M against sales at will

By person

19 insiders · 1 transaction

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Davis George Eric

EVP, Chief Legal Officer

—

$1.16M (1)

−$1.16M

61,003

0.0315%

$4.04M

+7.9%

Hardy Alexander

Chief Executive Officer

—

214,635

0.1109%

$14.23M

+44.9%

MEIER RICHARD A

Director

—

127,426

0.0658%

$8.45M

+5.5%

Mueller Brian

EVP, Chief Financial Officer

—

123,314

0.0637%

$8.17M

+71.4%

Guyer Charles Greg

EVP, Chief Technical Officer

—

84,140

0.0435%

$5.58M

+12.9%

Friberg Gregory R

EVP, Chief R&D Officer

—

51,818

0.0268%

$3.43M

+12,920%

HOMBACH ROBERT J.

Director

—

49,360

0.0255%

$3.27M

+40.1%

Dere Willard H

Director

—

46,440

0.0240%

$3.08M

+43.8%

Hubbard Cristin

EVP, Chief Commercial Officer

—

42,472

0.0219%

$2.82M

+118.1%

ANDERSON ELIZABETH M

Director

—

41,940

0.0217%

$2.78M

+50.9%

Ho Maykin

Director

—

35,500

0.0183%

$2.35M

+66.2%

Ramchandani Rashmi Virendra

VP, Chief Accounting Officer

—

25,610

0.0132%

$1.70M

—

Bodem Barbara W.

Director

—

21,045

0.0109%

$1.39M

+204.8%

Enyedy Mark J

Director

—

21,040

0.0109%

$1.39M

+204.9%

Countouriotis Athena

Director

—

21,040

0.0109%

$1.39M

+204.9%

Walbert Timothy P

Director

—

17,270

0.0089%

$1.14M

—

CLARK IAN T

Director

—

14,490

0.0075%

$960.46K

—

Burkhart Erin

GVP, Chief Accounting Officer

—

14,173

0.0073%

$939.44K

−1.9%

Plenge Robert M

Director

—

6,140

0.0032%

$406.98K

—

BIOMARIN PHARMACEUTICAL INC

By person

Individual transactions

What was left out